Peginterferon alfa-2b

News and Video Search Results

News coverage

Ascletis Announces Poster Presentation of Phase II Study of ASC42 FXR Agonist for Functional Cure of Chronic Hepatitis B at EASL CONGRESS 2023
PR Newswire Asia 26 Jun 2023
Hepatitis C Market is Expected to Drive Growth at 14.2% By 2032
GlobeNewswire 13 Jun 2023

Checkpoint Inhibitors for Treating Cancer Market Worth US$ 63,420.2 Million by 2031: Visiongain Reports Ltd
GlobeNewswire 29 Aug 2022
Checkpoint Inhibitors for Treating Cancer Market Worth US$ 63,420.2 Million by 2031: Visiongain Research Inc
GlobeNewswire 07 Apr 2022

You might like